About
Technology
Issues
FAQ
Links
Official Page
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.